Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Osteosarcoma 1Non-Muscle Invasive Bladder Neoplasms 1Carcinoma in Situ 1

Interventions

X-Rays 8Specimen Handling 8Cyclophosphamide 8Phantoms, Imaging 7Magnetic Resonance Spectroscopy 6fludarabine 5cabozantinib 5Gemcitabine 5Biopsy 5Nuclear Medicine Department, Hospital 4Methotrexate 4Doxorubicin 4fludarabine phosphate 3Ifosfamide 3Cisplatin 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2pembrolizumab 2palbociclib 2olaparib 2mifamurtide 2larotrectinib 2ivosidenib 2irinotecan sucrosofate 2ensartinib 2atezolizumab 2Vincristine 2Temozolomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Clinical Trials, Phase II as Topic × 90 days × Clear all
NCT07357519 2026-05-01

Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)

Lantheus Medical Imaging

Phase 1/2 Recruiting
55 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡